Cardiorenal Syndrome clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
The goal of this trial is to evaluate whether subantimicrobial-dose of doxycycline (20mgBID) will affect serum and urine biomarkers of fibrosis in patients with pre-dialysis chronic kidney disease.
San Francisco, California
Last updated: April 30, 2018